Pentadecanoic acid as an emerging microbial–metabolic node for cardiometabolic health
Trends in Endocrinology & Metabolism · 2026-11
DOI: 10.1016/j.tem.2026.11.004 ↗Kurz gefasst
Fachartikel in der Zeitschrift Trends in Endocrinology & Metabolism, 2026-11. Verfasst von Ruoyi Yang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Birth Defects and Related Diseases of Women and Children of MOE, National Health Commission Key Laboratory of Chronobiology, Childr…. Die Arbeit nennt 10 Literaturangaben.
Abstract (Originalsprache)
The mechanisms underlying the gut microbiota's role in cardiometabolic health remain largely unknown. In a recent article in Nature, Yin et al. identify pentadecanoic acid from Bacteroides uniformis as an HMG-CoA reductase inhibitor that regulates cholesterol metabolism and atherosclerosis. This work reveals an unrecognized microbial-metabolic axis for cardiometabolic health.
Autor:innen und Institutionen
- Key Laboratory of Birth Defects and Related Diseases of Women and Children of MOE, National Health Commission Key Laboratory of Chronobiology, Children's Medicine Key Laboratory of Sichuan Province, West China Second Un…
Zitieren
APA
Yang, R., Deng, C., & Tang, X. (2026). Pentadecanoic acid as an emerging microbial–metabolic node for cardiometabolic health. Trends in Endocrinology & Metabolism. https://doi.org/10.1016/j.tem.2026.11.004
Vancouver
Yang R, Deng C, Tang X. Pentadecanoic acid as an emerging microbial–metabolic node for cardiometabolic health. Trends in Endocrinology & Metabolism. 2026. doi:10.1016/j.tem.2026.11.004
BibTeX
@article{Yang2026,
author = {Yang, Ruoyi and Deng, Cechuan and Tang, Xiaoqiang},
title = {Pentadecanoic acid as an emerging microbial–metabolic node for cardiometabolic health},
journal = {Trends in Endocrinology & Metabolism},
year = {2026},
doi = {10.1016/j.tem.2026.11.004}
}
EUVIMED